Page 151 - Coronavirus Vaccine

Top headlines: HC setback for Future Group; 5,481 new Covid cases in Delhi

Business Standard brings you the top headlines on Tuesday

Cordelia Cruise operator claims guests infected before boarding

It also announced suspension of its January 5 service

Dr Reddy's to launch Molflu at Rs 35 per capsule for Covid treatment

The overall cost for a patient treated with a 5-day course of 40 capsules of the generic drug, to be sold under brand name 'Molflu', will come up to Rs 1,400

Covid antiviral drug Molnupiravir launched in India for moderate infection

Covid antiviral drug Molnupiravir was launched in India at Rs 1,399 for a five-day course for mild to moderate infection

T-cells can aid in fight against Omicron if antibodies fail, says study

Researchers have found that T cells - one of the body's key defences against Covid-19, can mount an effective immune response against Omicron, if antibodies fail to do that.

Why are so many vaccinated people getting Covid-19 lately

Why are so many vaccinated people getting COVID-19 lately? A couple of factors are at play, starting with the emergence of the highly contagious omicron variant. Omicron is more likely to infect people, even if it doesn't make them very sick, and its surge coincided with the holiday travel season in many places. People might mistakenly think the COVID-19 vaccines will completely block infection, but the shots are mainly designed to prevent severe illness, says Louis Mansky, a virus researcher at the University of Minnesota. And the vaccines are still doing their job on that front, particularly for people who've gotten boosters. Two doses of the Pfizer-BioNTech or Moderna vaccines or one dose of the Johnson & Johnson vaccine still offer strong protection against serious illness from omicron. While those initial doses aren't very good at blocking omicron infection, boosters particularly with the Pfizer and Moderna vaccines rev up levels of the antibodies to help fend off ...

Rising Omicron cases can impact growth by 0.3% in March quarter: Report

The downside risks at the current juncture emanate from more states imposing restrictions, the restrictions extending beyond January 2022 and also a slowdown in global recovery: Economists

Covid-19: A dozen days of lockdown spurs angst in China's Xi'an

Shortages of food and medical care have worsened over the past 12 days since officials sealed off the city of 13 million people

Covid-19 infections in Odisha more than double in four days

The State has reported 680 fresh cases on Monday, which is more than double of the cases reported on January 1

5,500 new Covid cases reported in Delhi; weekend curfew not lockdown: Jain

Nearly 5,500 fresh cases of Covid have been reported in Delhi on Tuesday with a positivity rate of about 8.5%, Health Minister Satyendar Jain said

Lockdown will be imposed in Mumbai if daily Covid cases cross 20,000: Mayor

Maharashtra Chief Minister Uddhav Thackeray might address the citizens in a couple of days, the mayor said

33 Medanta hospital staff test positive for Covid-19 in Lucknow

As many as 33 medical staff, including doctors, at Medanta hospital in Lucknow have tested positive for Covid-19, the hospital said

Covid-19: Omicron cases rise to 1,892 in India, Maharashtra worst-hit

With 192 new cases of highly transmissible Covid variant Omicron detected in the last 24 hours, India's Omicron tally on Tuesday rose to 1,892 cases.

80 doctors, students at Patiala medical college test positive for Covid-19

This comes as Patiala is turning out to be the worst-hit district in Punjab in terms of a rising number of coronavirus cases

SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose

SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose

RNA-based therapy can protect from many Covid-19 variants: Study

An RNA molecule that stimulates the body's early antiviral defence system may provide protection against a range of SARS-CoV-2 variants, including Delta, according to a study conducted in mice. Ribonucleic acid (RNA) is a single stranded molecule essential in various biological roles and expression of genes. Researchers at Yale School of Medicine in the US noted that the molecule could lead to new treatments for COVID-19 in immunocompromised patients. The research, published recently in the Journal of Experimental Medicine (JEM), could also provide an inexpensive therapeutic option for many developing countries that currently lack access to vaccines. The study was conducted before Omicron was identified and did not test for the variant which is behind the current spike in COVID-19 cases in many countries. The researchers noted that the vaccines against SARS-CoV-2 are highly effective at preventing severe disease and death. However, vaccine availability is extremely limited in man

Surge in cases indicative of third Covid-19 wave in India: Expert

Omicron is being detected in most of the states in the country, Dr N K Arora, the chairman of the COVID-19 working group of the NTAGI, said on Tuesday

DATA STORY: India logs 37,379 new cases, most since September 9

India has so far administered 1,467,018,464 vaccine doses. That is 4196.24 per cent of its total caseload, and 104.87 per cent of its population

US FDA authorises Pfizer-BioNTech booster shots for kids aged 12-15

The US FDA has expanded the emergency use authorisation for the Pfizer-BioNTech Covid-19 vaccine boosters to children aged 12 to 15.

Over 1 mn Covid cases reported in US amid rapid spread of Omicron variant

The US on Monday reported over 1 million COVID-19 cases amid rapid spread of the Omicron variant.The US health authorities registered more than three times as many new cases as in any previous wave of the coronavirus, over 1 million reported on Monday alone, reported USA TODAY.A substantial increase in coronavirus infections was expected when this week's numbers came out, but nothing like this. About 1 of every 100 Americans will have been reported as a positive case in just the last week, according to data from Johns Hopkins University.On Tuesday, President Joe Biden and Vice President Kamala Harris planned to meet with the White House coronavirus response team to discuss a course of action as omicron becomes ubiquitous, reported USA TODAY.By 7:30 pm ET Monday, Johns Hopkins University data showed about 1,042,000 more cases than the day before, and it wasn't immediately clear that all states had reported in. That count clearly includes hefty numbers of backlogged cases.About ...